WHO
REGULATORY UPDATE
3rd Invitation to Manufacturers of medicinal products for management of diabetes to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit
Published: 7/1/2026Detected: 5/11/2026
Summary preview
Updates WHO’s Expression of Interest (EOI) process for manufacturers seeking WHO Prequalification Unit product evaluation for medicines used in diabetes management.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountmanufacturing
quality
clinical
safety
labeling
gastroenterology
#WHO prequalification
#expression of interest (EOI)
#insulin analogues
#semaglutide
#diabetes management
Official Source Document Source Verified
Access the original document directly from WHO.
More from WHO
- New Deadline for Submission: Request for Quotations (RFQ) from interested Notified Bodies - WHO Prequalification Assessment for Medical Devices10/2/2026
- PQT/AMD newsletter - Q3 2026, Issue 54 is now available10/2/2026
- PQ Webinar: Launch of WHO Prequalification of Medical Devices10/2/2026
- New EUL listing10/2/2026
- Prequalification of In Vitro Diagnostics: Scope Expansion10/2/2026